Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR super(+) breast cancer: the ProBONE II studyOsteoporosis international, 2014-04, Vol.25 (4), p.1369-1378 [Peer Reviewed Journal]ISSN: 0937-941X ;EISSN: 1433-2965 ;DOI: 10.1007/s00198-013-2615-zFull text available |
|
2 |
Material Type: Article
|
Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by super(18)F-FDG PET/CT in squamous cell carcinoma of the oral cavityEuropean journal of nuclear medicine and molecular imaging, 2014-03, Vol.41 (3), p.452-461 [Peer Reviewed Journal]ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-013-2571-zFull text available |
|
3 |
Material Type: Article
|
The mechanism of action of MF59 – An innately attractive adjuvant formulationVaccine, 2012-06, Vol.30 (29), p.4341-4348 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 19, 2012 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.09.061 ;PMID: 22682289Full text available |
|
4 |
Material Type: Article
|
HYPOFRACTIONATION WITH TOMOTHERAPY FOR PROSTATE CANCER: TOXICITIES AND OUTCOMES IN 82 PATIENTS TREATED IN MODENAAnticancer research, 2013-05, Vol.33 (5), p.2262-2263 [Peer Reviewed Journal]ISSN: 0250-7005 ;EISSN: 1791-7530Full text available |
|
5 |
Material Type: Article
|
Adjuvant Pembrolizumab versus Placebo in Resected Stage III MelanomaThe New England journal of medicine, 2018-05, Vol.378 (19), p.1789-1801 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;(c) Massachusetts Medical Society, 2018 info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1802357 ;PMID: 29658430Full text available |
|
6 |
Material Type: Article
|
TLR-based immune adjuvantsVaccine, 2011-04, Vol.29 (17), p.3341-3355 [Peer Reviewed Journal]2010 ;Published by Elsevier Ltd. ;Copyright Elsevier Limited Apr 12, 2011 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2010.08.002 ;PMID: 20713100Full text available |
|
7 |
Material Type: Article
|
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or OlderThe Journal of infectious diseases, 2017-12, Vol.216 (11), p.1352-1361 [Peer Reviewed Journal]The Author 2017 ;The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. 2017 ;The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jix481 ;PMID: 29029224Full text available |
|
8 |
Material Type: Article
|
self-assembling peptide acting as an immune adjuvantProceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (2), p.622-627 [Peer Reviewed Journal]Copyright National Academy of Sciences Jan 12, 2010 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0912124107 ;PMID: 20080728Full text available |
|
9 |
Material Type: Article
|
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus DiseaseInternational journal of molecular sciences, 2022-02, Vol.23 (3), p.1850 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms23031850 ;PMID: 35163772Full text available |
|
10 |
Material Type: Article
|
Alum adjuvant: some of the tricks of the oldest adjuvantJournal of medical microbiology, 2012-07, Vol.61 (Pt 7), p.927-934 [Peer Reviewed Journal]ISSN: 0022-2615 ;EISSN: 1473-5644 ;DOI: 10.1099/jmm.0.038943-0 ;PMID: 22174375Full text available |
|
11 |
Material Type: Article
|
A novel mitogen fusion protein against CD40 super(+) cells with potent vaccine adjuvant propertiesVaccine, 2010-05, Vol.28 (21), p.3688-3695 [Peer Reviewed Journal]ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2010.03.014Full text available |
|
12 |
Material Type: Article
|
Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine AdjuvantsFrontiers in immunology, 2022-05, Vol.13, p.847616-847616 [Peer Reviewed Journal]Copyright © 2022 Hioki, Hayashi, Natsume-Kitatani, Kobiyama, Temizoz, Negishi, Kawakami, Fuchino, Kuroda, Coban, Kawahara and Ishii. ;Copyright © 2022 Hioki, Hayashi, Natsume-Kitatani, Kobiyama, Temizoz, Negishi, Kawakami, Fuchino, Kuroda, Coban, Kawahara and Ishii 2022 Hioki, Hayashi, Natsume-Kitatani, Kobiyama, Temizoz, Negishi, Kawakami, Fuchino, Kuroda, Coban, Kawahara and Ishii ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.847616 ;PMID: 35663999Full text available |
|
13 |
Material Type: Article
|
Prothymosin [alpha] and a prothymosin [alpha]-derived peptide enhance T sub(H)1-type immune responses against defined HER-2/neu epitopesBMC immunology, 2013-01, Vol.14 (1), p.43-43 [Peer Reviewed Journal]ISSN: 1471-2172 ;EISSN: 1471-2172 ;DOI: 10.1186/1471-2172-14-43Full text available |
|
14 |
Material Type: Article
|
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV MelanomaThe New England journal of medicine, 2017-11, Vol.377 (19), p.1824-1835 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709030 ;PMID: 28891423Full text available |
|
15 |
Material Type: Article
|
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older AdultsThe New England journal of medicine, 2023-02, Vol.388 (7), p.595-608 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209604 ;PMID: 36791160Full text available |
|
16 |
Material Type: Article
|
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated MelanomaThe New England journal of medicine, 2017-11, Vol.377 (19), p.1813-1823 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1708539 ;PMID: 28891408Full text available |
|
17 |
Material Type: Article
|
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patientsJournal for immunotherapy of cancer, 2019-06, Vol.7 (1), p.163-13, Article 163 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1186/s40425-019-0625-x ;PMID: 31248461Full text available |
|
18 |
Material Type: Article
|
CpG DNA as a vaccine adjuvantExpert review of vaccines, 2011-04, Vol.10 (4), p.499-511 [Peer Reviewed Journal]Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.10.174 ;PMID: 21506647Full text available |
|
19 |
Material Type: Book
|
Databook of Rheological AdditivesISBN: 9781927885918 ;ISBN: 1927885914 ;EISBN: 9781927885925 ;EISBN: 1927885922 ;DOI: 10.1016/C2021-0-00232-7Full text available |
|
20 |
Material Type: Article
|
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2021-02, Vol.397 (10275), p.682-694 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00241-5 ;PMID: 33524311Full text available |